Abstract Background: Alzheimer's disease (AD) is the commonest dementia, which has no recognized cure. It causes deterioration as it advances, and ultimately results in death. AD was primarily defined by German psychiatric specialist and neuropathologist, Alois Alzheimer. Frequently, AD Alzheimer’s disease is diagnosed in persons above the age of 65 years, even though the less common early-onset of the disease can happen. It is anticipated that more than 3 million individuals aged 85 and more will have Alzheimer's. 33% of Americans over age 85 are burdened with the disease while 5.3 million Americans are living with Alzheimer's disease. Unless a cure is found, close to 16 million Americans will have the disease by 2050. Alzheimer’s...
BACKGROUND: Hospitalization, frequently complicated by delirium, can be a life-changing event for pa...
Alzheimer's disease is a progressive degenerative condition that has devastating implications for th...
Objective: To review the literature on prevalence, costs, and treatment of Alzheimer’s disease and r...
Background and Objective: In 2014, an estimated 5.2 million Americans were living with Alzheimer’s d...
OBJECTIVES: The goal of this study was to project the future prevalence and incidence of Alzheimer's...
Onur Başer (MEF Author)OBJECTIVES: To compare healthcare utilization and costs between early- andlat...
Alzheimer’s disease and related dementias (ADRD) affect millions of people worldwide; however, there...
Objective: To describe factors associated with survival in Alzheimer disease (AD) in a multiethnic, ...
BACKGROUND: Alzheimer's disease (AD) is a neurodegenerative disorder incurring significant social an...
Background. Prior studies offer conflicting findings on whether Alzheimer's disease (AD) is ass...
Introduction:Alzheimer\u2019s disease and related dementias (ADRD) cause a high burden of morbidity ...
Background: Alzheimer's disease (AD) is a neurodegenerative disorder incurring significant soci...
Objective: To describe factors associated with survival in Alzheimer disease (AD) in a multiethnic, ...
AbstractThis report discusses the public health impact of Alzheimer's disease (AD), including incide...
Alzheimer’s disease is a progressive disease that impairs cognitive and functional abilities. Withou...
BACKGROUND: Hospitalization, frequently complicated by delirium, can be a life-changing event for pa...
Alzheimer's disease is a progressive degenerative condition that has devastating implications for th...
Objective: To review the literature on prevalence, costs, and treatment of Alzheimer’s disease and r...
Background and Objective: In 2014, an estimated 5.2 million Americans were living with Alzheimer’s d...
OBJECTIVES: The goal of this study was to project the future prevalence and incidence of Alzheimer's...
Onur Başer (MEF Author)OBJECTIVES: To compare healthcare utilization and costs between early- andlat...
Alzheimer’s disease and related dementias (ADRD) affect millions of people worldwide; however, there...
Objective: To describe factors associated with survival in Alzheimer disease (AD) in a multiethnic, ...
BACKGROUND: Alzheimer's disease (AD) is a neurodegenerative disorder incurring significant social an...
Background. Prior studies offer conflicting findings on whether Alzheimer's disease (AD) is ass...
Introduction:Alzheimer\u2019s disease and related dementias (ADRD) cause a high burden of morbidity ...
Background: Alzheimer's disease (AD) is a neurodegenerative disorder incurring significant soci...
Objective: To describe factors associated with survival in Alzheimer disease (AD) in a multiethnic, ...
AbstractThis report discusses the public health impact of Alzheimer's disease (AD), including incide...
Alzheimer’s disease is a progressive disease that impairs cognitive and functional abilities. Withou...
BACKGROUND: Hospitalization, frequently complicated by delirium, can be a life-changing event for pa...
Alzheimer's disease is a progressive degenerative condition that has devastating implications for th...
Objective: To review the literature on prevalence, costs, and treatment of Alzheimer’s disease and r...